Serum chemokine profile in patients with bullous pemphigoid

Summary Background Bullous pemphigoid (BP) is an autoimmune inflammatory disease causing blister formation at the dermoepidermal junction. Cutaneous infiltration of activated CD4+ T cells and eosinophils is an early event in blister formation during the disease process, suggesting that the trafficking of circulating leucocytes through the sites of inflammation is crucial in the pathogenesis of the disease. While the accumulated evidence suggests that some cytokines are involved in the pathogenesis, there have been few reports about serum chemokine profiles in patients with BP. Objectives To determine serum profiles of various chemokines and their clinical association in patients with BP. Methods Concentrations of 10 chemokines – interferon (IFN)‐γ‐inducible protein‐10 (IP‐10), monokine induced by IFN‐γ (MIG), macrophage inflammatory protein (MIP)‐1α, MIP‐1β, RANTES, eotaxin, monocyte chemoattractant protein (MCP)‐1, MCP‐2, MCP‐3 and growth‐regulated oncogene‐α– were measured in serum samples from 38 patients with BP, 16 with pemphigus vulgaris (PV) and 17 normal controls using a sandwich immunoassay‐based multiplex protein array system. Results While there was no significant increase in any serum chemokine levels in patients with PV, serum levels of IP‐10 and MCP‐1 were significantly increased in patients with BP compared with healthy controls. Furthermore, serum levels of IP‐10, MIG, MCP‐1 and eotaxin in patients with BP increased significantly with disease severity as determined by the area affected. Conclusions These observations suggest that an elaborately orchestrated network of chemokines, especially MCP‐1 and IP‐10, contributes to the pathomechanism of BP.